✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Bayer AG

Common Name
Bayer
Country
Germany
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
87,280
Ticker
BAYN
Exchange
XETRA
Description
Bayer AG is a global life science company operating in healthcare and nutrition sectors. It functions through three primary segments: Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceut...

Bayer's GHG Emissions Data Preview

In 2025, Bayer completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Bayer has also provided a category-level breakdown for 14 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202520242023
2022 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metricb
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metricb
0000000
Location-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metricb
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metricb
0000000
Limited Data Preview
You are viewing a limited preview of Bayer’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2019, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=BAYN&reporting_period=2025"

Verified Sources Behind Bayer’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bayer’s data sources below and access millions more through our Disclosure Search.

a. Bayer's Integrated Report 2025
b. Bayer's Annual Report 2024

Insights into Bayer's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Bayer amounted to 3,370,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Bayer decreased by 4.53%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Bayer's Scope 1 Emissions Over Time

20192020202120222023202420250550 k1.1 M1.65 M2.2 MtCO2e-3%-4%-1%-1%-1%+1%
  • Total Scope 1
  • Year-over-Year Change

What are Bayer's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Bayer were 1,890,000 metric tons of CO₂ equivalent (tCO₂e).a

Has Bayer reduced its Scope 1 emissions over time?

Since 2019, Bayer's Scope 1 emissions have decreased by 9.13%, reflecting a declining long-term trend in Scope 1 emissions over time.a

Compared to the previous year (2024), Bayer's Scope 1 emissions remained relatively stable, indicating that Bayer's emissions have plateaued with no significant change in its operational footprint.a

What are Bayer's Scope 2 emissions?

In 2025, Bayer reported Scope 2 greenhouse gas (GHG) emissions of 900,000 tCO₂e using the market-based method and 1,480,000 tCO₂e using the location-based method.a

Has Bayer reduced its Scope 2 emissions over time?

Since 2019, Bayer's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 16.38%, reflecting a declining long-term trend in Scope 2 emissions over time.a

Compared to the previous year (2024), Bayer's Scope 2 emissions (Location-Based) fell by 10.3% in 2025, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a

What methodology does Bayer use for Scope 2 reporting?

In 2025, Bayer reported its Scope 2 emissions using the market-based method and using the location-based method.a

Bayer's Scope 2 Emissions Over Time

20192020202120222023202420250450 k900 k1.35 M1.8 MtCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Bayer's Value Chain Emissions

In 2025, Bayer reported 9,100,000 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2025 disclosure of Bayer includes a breakdown across 14 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Bayer's Scope 3 Emissions Over Time

201920202021202220232024202503 M6 M9 M12 MtCO2e-14%0%+9%-6%-4%+3%
  • Total Scope 3
  • Year-over-Year Change

What are Bayer's Scope 3 emissions?

In 2025, Bayer reported total Scope 3 emissions of 9,100,000 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 94.64% of these emissions originated from upstream activities such as purchased goods and capital goods, while 5.36% came from downstream activities like product use, distribution, and end-of-life treatment.a

Has Bayer reduced its Scope 3 emissions over time?

Since 2019, Bayer's Scope 3 emissions have decreased by 11.99%, reflecting a declining long-term trend in Scope 3 emissions over time.a

Compared to the previous year (2024), Bayer's Scope 3 emissions remained relatively stable, indicating that Bayer's emissions have plateaued with no significant change in its value chain footprint.a

What categories of Scope 3 emissions does Bayer disclose?

In 2025, Bayer reported emissions for 14 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Bayer's Scope 3 emissions?

In 2025, the largest contributors to Bayer's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 6,250,000 tCO₂e (68.51%)
  • Upstream Transportation and Distribution (Cat. 4): 820,000 tCO₂e (8.99%)
  • Fuel- and Energy-Related Services (Cat. 3): 670,000 tCO₂e (7.34%)

Bayer's Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(68.5%)Fuel- andEnergy-RelatedServices (Cat. 3)(7.3%)UpstreamTransportation andDistribution(Cat. 4)(9.0%)

Insights into Bayer’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Bayer reported Scope 1 greenhouse gas (GHG) emissions of 1,890,000 tCO₂e and total revenues of USD 53,581 millions. This translates into an emissions intensity of 35.27 tCO₂e per millions USD.a

Bayer's Scope 1 Emissions Intensity Compared to Peers

1002,00020,000500,00010,000,000Scope 1 Emissions (tCO2e)1005005,00050,000200,000Revenues (Millions of USD)SZOGlaxoSmithKline PharmaceuticalsYear: 2025Scope 1: 1,003 tCO2eRevenue: $M 436Scope 1 Intensity: 2.30 tCO2e/$MBristol-Myers SquibbYear: 2024Scope 1: 206,726 tCO2eRevenue: $M 48,300Scope 1 Intensity: 4.28 tCO2e/$MJohnson & JohnsonYear: 2024Scope 1: 314,690 tCO2eRevenue: $M 88,820Scope 1 Intensity: 3.54 tCO2e/$MNovo NordiskYear: 2025Scope 1: 120,000 tCO2eRevenue: $M 48,646Scope 1 Intensity: 2.47 tCO2e/$MJCR PharmaceuticalsYear: 2022Scope 1: 3,315 tCO2eRevenue: $M 419Scope 1 Intensity: 7.92 tCO2e/$MSSSanofi IndiaYear: 2024Scope 1: 510 tCO2eRevenue: $M 232Scope 1 Intensity: 2.20 tCO2e/$MGilead SciencesYear: 2024Scope 1: 53,856 tCO2eRevenue: $M 28,754Scope 1 Intensity: 1.87 tCO2e/$MCosmo PharmaceuticalsYear: 2024Scope 1: 5,658 tCO2eRevenue: $M 278Scope 1 Intensity: 20.38 tCO2e/$MSanten PharmaceuticalYear: 2024Scope 1: 17,372 tCO2eRevenue: $M 1,994Scope 1 Intensity: 8.71 tCO2e/$MMerck KGaAYear: 2025Scope 1: 657,835 tCO2eRevenue: $M 24,809Scope 1 Intensity: 26.52 tCO2e/$MOno PharmaceuticalYear: 2024Scope 1: 8,100 tCO2eRevenue: $M 3,319Scope 1 Intensity: 2.44 tCO2e/$MKalbe FarmaYear: 2024Scope 1: 19,895 tCO2eRevenue: $M 2,028Scope 1 Intensity: 9.81 tCO2e/$MZZZhangzhou Pientzehuang PharmaceuticalYear: 2023Scope 1: 2,301 tCO2eRevenue: $M 1,415Scope 1 Intensity: 1.63 tCO2e/$MPfizerYear: 2024Scope 1: 613,218 tCO2eRevenue: $M 63,627Scope 1 Intensity: 9.64 tCO2e/$MChugai PharmaceuticalYear: 2024Scope 1: 51,143 tCO2eRevenue: $M 7,456Scope 1 Intensity: 6.86 tCO2e/$MAmgenYear: 2024Scope 1: 147,000 tCO2eRevenue: $M 33,424Scope 1 Intensity: 4.40 tCO2e/$MVirbacYear: 2024Scope 1: 10,966 tCO2eRevenue: $M 1,454Scope 1 Intensity: 7.54 tCO2e/$MOrganon & CoYear: 2024Scope 1: 34,200 tCO2eRevenue: $M 6,403Scope 1 Intensity: 5.34 tCO2e/$MAbbVieYear: 2024Scope 1: 300,072 tCO2eRevenue: $M 56,334Scope 1 Intensity: 5.33 tCO2e/$MDaiichi SankyoYear: 2024Scope 1: 91,836 tCO2eRevenue: $M 10,576Scope 1 Intensity: 8.68 tCO2e/$MGSKYear: 2024Scope 1: 521,000 tCO2eRevenue: $M 39,374Scope 1 Intensity: 13.23 tCO2e/$MRoche HoldingYear: 2025Scope 1: 211,962 tCO2eRevenue: $M 79,968Scope 1 Intensity: 2.65 tCO2e/$MMerck & Co IncYear: 2024Scope 1: 721,200 tCO2eRevenue: $M 64,168Scope 1 Intensity: 11.24 tCO2e/$MOOOrion OyjYear: 2025Scope 1: 5,018 tCO2eRevenue: $M 2,221Scope 1 Intensity: 2.26 tCO2e/$MBayerYear: 2025Scope 1: 1,890,000 tCO2eRevenue: $M 53,581Scope 1 Intensity: 35.27 tCO2e/$M

How does Bayer's GHG emissions intensity compare to its peers?

In 2025, Bayer reported a Scope 1 emissions intensity of 35.27 tCO₂e per millions USD. Compared to the peer group median of 5.33, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Bayer rank on GHG emissions intensity within its industry?

In 2025, Bayer ranked 25 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Bayer among the least efficient performers, with one of the highest emissions intensities in its sector.a

Insights into Bayer's Total Carbon Footprint

In 2025, Bayer reported a total carbon footprint of 12,470,000 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 0.97% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Bayer's total carbon footprint was Scope 3 emissions, accounting for 72.98% of the company's total carbon footprint, followed by Scope 1 emissions at 15.16%.a

Want Full Access to Bayer's GHG Emissions Dataset?
Start 30-Day Free Trial